Oncology Associates
About Us
Professional Staff
Contact Us
Oncology Associates
HomeServicesPatient InfoNewsEventsResearch
Cedar Rapids Oncology Project

Clinical Trials are research studies that try to find better ways to prevent, diagnose, or treat cancer. The Cedar Rapids Oncology Project (CROP) is a non-profit organization affiliated with Oncology Associates, Mercy Medical Center, St. Luke's Hospital, and Trinity Medical Center in the Quad Cities area. The Project began in 1985 for the purpose of providing access to cancer Clinical Research Trials to people in Eastern Iowa. CROP is one of 50 National Cancer Institute (NCI) Community Clinical Oncology Programs in the US.

CROP has expanded from cancer treatment research and now includes cancer prevention and cancer screening clinical trials. The Project provides two important benefits:
  • Physicians practicing in the community are well informed about and are using the newest cancer therapies.
  • Cancer patients are receiving the newest medications and therapies in their own local communities.
The funding for these research efforts comes from an NCI Grant each year along with support from The Cedar Rapids Oncology Project (CROP), Mercy Medical Center, St. Luke's Hospital, and Trinity Medical. Clinical trials opened by Cedar Rapids Oncology Project come primarily from the North Central Cancer Treatment Group based at the Mayo Clinic in Rochester MN. The Project is also a member of the Eastern Cooperative Oncology Group (ECOG), the Clinical Trials Support Unit and has access to pharmaceutical industry clinical trials.

For more information about clinical trials call (319) 363-2690 or e-mail larens@mercycare.org.

Contact Us

Website Privacy Policy  |  Disclaimer  

Home ·  Services ·  Patient Info ·  News ·  Events ·  Research ·  About Us ·  Professional Staff ·  FAQ ·  Contact Us

Copyright 2014 Oncology Associates at Mercy Medical Center, All Rights Reserved.
701 10th St. SE  ·  Cedar Rapids, IA 52403  ·  319.363.8303
Designed and maintained by Informatics, Inc.